Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Go back to Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update
(NASDAQ: TSHA) Delayed: 6.42 +0.23 (3.72%)
Previous Close $6.19    52 Week High
Open $6.24    52 Week Low
Day High $6.57    P/E N/A 
Day Low $6.24    EPS
Volume 6,368,908